[1]
T. Nurseta, D. E. P. Harnandari, P. A. Herliawati, M. Nooryanto, and P. Handayani, “Risk Of Malignancy Index 4 Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma Used for Neoadjuvant Chemotherapy”, Med.Lab.Tech.J., vol. 7, no. 2, pp. 101–111, Dec. 2021.